Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acusphere, Inc.
Acusphere, Inc. Reschedules IP Payments
June 6th, 2008
Acusphere, Inc. (NASDAQ: ACUS) announced that it had completed the renegotiation of payment terms under certain intellectual property agreements. Payments due in the 12 months ending March 31, 2009 have been reduced by $3.5 million and shifted out by the same amount to later in 2009. The Company expects a full response letter from the FDA on its recently filed NDA for Imagify(TM) (Perflubutane Polymer Microspheres) for Injectable Suspension, on or around the PDUFA date in Q1 2009. Lawrence A. Gyenes, Chief Financial Officer of Acusphere, said, "We are very pleased to reach these agreements. They allow us to conserve cash, as we continue to work diligently on a range of...
Source: Health Business Week (2008-06-06)
|
